193 related articles for article (PubMed ID: 22269938)
1. Generation of wear during the production of drug nanosuspensions by wet media milling.
Juhnke M; Märtin D; John E
Eur J Pharm Biopharm; 2012 May; 81(1):214-22. PubMed ID: 22269938
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.
Kim JH; Jang SW; Han SD; Hwang HD; Choi HG
Pharmazie; 2011 Jul; 66(7):491-5. PubMed ID: 21812323
[TBL] [Abstract][Full Text] [Related]
3. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
[TBL] [Abstract][Full Text] [Related]
4. Process and scaling parameters for wet media milling in early phase drug development: A knowledge based approach.
Siewert C; Moog R; Alex R; Kretzer P; Rothenhäusler B
Eur J Pharm Sci; 2018 Mar; 115():126-131. PubMed ID: 29278757
[TBL] [Abstract][Full Text] [Related]
5. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
6. Analysis of heat generation during the production of drug nanosuspensions in a wet stirred media mill.
Guner G; Seetharaman N; Elashri S; Mehaj M; Bilgili E
Int J Pharm; 2022 Aug; 624():122020. PubMed ID: 35842083
[TBL] [Abstract][Full Text] [Related]
7. An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.
Li M; Zhang L; Davé RN; Bilgili E
AAPS PharmSciTech; 2016 Apr; 17(2):389-99. PubMed ID: 26182907
[TBL] [Abstract][Full Text] [Related]
8. Identification of critical process parameters and its interplay with nanosuspension formulation prepared by top down media milling technology--a QbD perspective.
Ghosh I; Schenck D; Bose S; Liu F; Motto M
Pharm Dev Technol; 2013; 18(3):719-29. PubMed ID: 23061898
[TBL] [Abstract][Full Text] [Related]
9. A microhydrodynamic rationale for selection of bead size in preparation of drug nanosuspensions via wet stirred media milling.
Li M; Alvarez P; Bilgili E
Int J Pharm; 2017 May; 524(1-2):178-192. PubMed ID: 28380391
[TBL] [Abstract][Full Text] [Related]
10. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling.
Ali HS; York P; Ali AM; Blagden N
J Control Release; 2011 Jan; 149(2):175-81. PubMed ID: 20946923
[TBL] [Abstract][Full Text] [Related]
11. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
[TBL] [Abstract][Full Text] [Related]
12. Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - Development of particle design method.
Niwa T; Miura S; Danjo K
Int J Pharm; 2011 Feb; 405(1-2):218-27. PubMed ID: 21167922
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.
Karakucuk A; Celebi N
Pharm Res; 2020 May; 37(6):111. PubMed ID: 32476048
[TBL] [Abstract][Full Text] [Related]
14. Use of Bead Mixtures as a Novel Process Optimization Approach to Nanomilling of Drug Suspensions.
Guner G; Kannan M; Berrios M; Bilgili E
Pharm Res; 2021 Jul; 38(7):1279-1296. PubMed ID: 34169438
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a riboflavin non-aqueous nanosuspension prepared by bead milling for cutaneous application.
Sato T; Takeuchi H; Sakurai T; Tanaka K; Matsuki K; Higashi K; Moribe K; Yamamoto K
Chem Pharm Bull (Tokyo); 2015; 63(2):88-94. PubMed ID: 25748779
[TBL] [Abstract][Full Text] [Related]
16. Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs.
Bhakay A; Merwade M; Bilgili E; Dave RN
Drug Dev Ind Pharm; 2011 Aug; 37(8):963-76. PubMed ID: 21323486
[TBL] [Abstract][Full Text] [Related]
17. Nano-sized crystalline drug production by milling technology.
Moribe K; Ueda K; Limwikrant W; Higashi K; Yamamoto K
Curr Pharm Des; 2013; 19(35):6246-58. PubMed ID: 23470002
[TBL] [Abstract][Full Text] [Related]
18. Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view.
Afolabi A; Akinlabi O; Bilgili E
Eur J Pharm Sci; 2014 Jan; 51():75-86. PubMed ID: 24036164
[TBL] [Abstract][Full Text] [Related]
19. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.
George M; Ghosh I
Eur J Pharm Sci; 2013 Jan; 48(1-2):142-52. PubMed ID: 23085547
[TBL] [Abstract][Full Text] [Related]
20. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
Monteiro A; Afolabi A; Bilgili E
Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
